NCT06247553 To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
| NCT ID | NCT06247553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2024-02-02 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2024-02-02 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test a gait (walking) training program in non-ambulatory (unable to walk) chronic stroke survivors. The main question it aims to answer is: • Will gait training improve the cardiovascular system in non-ambulatory chronic stroke survivors better than a sitting leg cycling exercise? Participants will walk on a treadmill with a partial body-weight support system and the gait training device. Researchers will compare with a leg-cycling exercise to see if there are significant differences in resting heart rate, systolic blood pressure (SBP), and A1c levels in the blood.
Eligibility Criteria
Inclusion Criteria: * must be 18 to 80 years old * male or female * independent ambulation before stroke * able to understand and follow verbal commands in English * have physicians' approval for exercise * be in a stable medical condition * must be after the first stroke * unable to walk independently * in the chronic stage (at least 6 months after stroke onset) Exclusion Criteria: * musculoskeletal or other disorders that prevent the participant from participating in the exercise * blood pressure higher than 200/110 mm Hg * diagnosis of severe depression * functionally restricted passive movement in the major joints of lower limbs * unable to speak or understand English * unable to travel to the Research Laboratory * currently participate in other walking training using treadmill with or without a body-weight support system * body weight greater than 400 lbs
Contact & Investigator
Wen Liu, PhD
PRINCIPAL INVESTIGATOR
University of Kansas Medical Center
Frequently Asked Questions
Who can join the NCT06247553 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06247553 currently recruiting?
Yes, NCT06247553 is actively recruiting participants. Contact the research team at cbailey8@kumc.edu for enrollment information.
Where is the NCT06247553 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT06247553 clinical trial?
NCT06247553 is sponsored by University of Kansas Medical Center. The principal investigator is Wen Liu, PhD at University of Kansas Medical Center. The trial plans to enroll 72 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.